MIT Lab Retracts Paper

A paper describing a new method for imaging synapse formation has been retracted after it emerged that the first author falsified data to prove its effectiveness.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, STEAKPINBALLA well-respected biochemist and rising star at the Massachusetts Institute of Technology (MIT) has retracted an important paper after an internal investigation found that her former postdoc faked the figures, reported Retraction Watch.

Alice Ting, named one of Technology Review’s “Innovators Under 35” in 2006, published the paper in question—which demonstrated a new way to image the mechanisms of synapse formation in the brain—in Cell in 2010. The first author was postdoc Amar Thyagarajan.

The paper was well-received, and Autism Speaks, which funded Thyagarajan’s postdoc, declared that “the ability to observe the active development of synapses will undoubtedly factor into future discoveries, paying dividends for some time to come.” The paper has since been cited 17 times, according to ISI Web of Knowledge

But yesterday (February 14), Cell retracted the paper. The accompanying notice explained that when Ting’s group discovered they could not reproduce the results, MIT started an investigation. Detailing the findings of that investigation in a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies